QT-Interval Dispersion and Myocardial Viability Response

被引:0
|
作者
Gadaleta, Francisco L. [1 ]
机构
[1] HIGA, Jefe Unidad Coronaria, Buenos Aires, DF, Argentina
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2009年 / 62卷 / 04期
关键词
ISCHEMIA;
D O I
10.1016/S0300-8932(09)70911-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:462 / 463
页数:2
相关论文
共 50 条
  • [31] Effects of carvedilol therapy on QT-interval dispersion in congestive heart failure - Is there a difference in the elderly?
    Rocha, RM
    Silva, GV
    Perin, EC
    Gerk, AR
    Gouvea, EP
    Santos, VMS
    Albanesi, FM
    de Albuquerque, DC
    TEXAS HEART INSTITUTE JOURNAL, 2003, 30 (03) : 176 - 179
  • [32] EFFECTS OF QUINIDINE VERSUS PROCAINAMIDE ON THE QT-INTERVAL
    REITER, MJ
    HIGGINS, SL
    PAYNE, AG
    MANN, DE
    AMERICAN JOURNAL OF CARDIOLOGY, 1986, 58 (06): : 512 - 516
  • [33] REDUCTION OF QT-INTERVAL IMPRECISION AND VARIANCE BY MEASURING THE JT INTERVAL
    SPODICK, DH
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (01): : 103 - 103
  • [34] Relation between QT dispersion and myocardial viability in ischemic cardiomyopathy
    Schinkel, AFL
    Bountioukos, M
    Poldermans, D
    Elhendy, A
    Valkema, R
    Vourvouri, EC
    Biagini, E
    Rizzello, V
    Kertai, MD
    Krenning, B
    Krenning, EP
    Roelandt, JRTC
    Bax, JJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (06): : 712 - 715
  • [35] Qt-interval prolongation caused by healthfood products?
    Gittermann, M.
    SWISS MEDICAL WEEKLY, 2008, 138 : 35S - 35S
  • [36] FAMILIAL PROLONGATION OF THE QT-INTERVAL WITH AND WITHOUT DEAFNESS
    BUTT, H
    BERGHORN, K
    HERZ KREISLAUF, 1980, 12 (02): : 89 - 92
  • [37] QT-INTERVAL MEASUREMENT - IMPORTANCE OF LEAD SELECTION
    COWAN, JC
    YUSOFF, K
    AMOS, PA
    GOLD, AE
    BOURKE, JP
    TANSUPHASWADIKUL, S
    CAMPBELL, RWF
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1987, 10 (04): : 1027 - 1027
  • [38] BEZAFIBRATE DOES NOT INFLUENCE THE QT-INTERVAL IN MAN
    OLSSON, AG
    EKELUND, LG
    LANG, PD
    VOLLMAR, J
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (02) : 341 - 342